{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:08Z","timestamp":1792421828935,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81600601"],"award-info":[{"award-number":["81600601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH363"],"award-info":[{"award-number":["ZR2021MH363"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02012-1","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T18:02:23Z","timestamp":1725300143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of low-purine diet on the serum uric acid of gout patients in different clinical subtypes: a prospective cohort study"],"prefix":"10.1186","volume":"29","author":[{"given":"Zhaoying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"issue":"10055","key":"2012_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039\u201352.","journal-title":"Lancet"},{"issue":"1","key":"2012_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.","journal-title":"BMC Med"},{"issue":"7","key":"2012_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11926-016-0594-8","volume":"18","author":"AB Vargas-Santos","year":"2016","unstructured":"Vargas-Santos AB, Taylor WJ, Neogi T. Gout classification criteria: update and implications. Curr Rheumatol Rep. 2016;18(7):46.","journal-title":"Curr Rheumatol Rep"},{"key":"2012_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.143460","volume":"759","author":"F Ahmed","year":"2021","unstructured":"Ahmed F, Tscharke B, O\u2019Brien JW, et al. Wastewater-based prevalence trends of gout in an Australian community over a period of 8 years. Sci Total Environ. 2021;759: 143460.","journal-title":"Sci Total Environ"},{"issue":"2","key":"2012_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","volume":"40","author":"E Roddy","year":"2014","unstructured":"Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am. 2014;40(2):155\u201375.","journal-title":"Rheum Dis Clin North Am"},{"key":"2012_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015: 762820.","journal-title":"Biomed Res Int"},{"issue":"5","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.1780080429","volume":"8","author":"LB Sorensen","year":"1965","unstructured":"Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965;8(5):694\u2013706.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2012_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/ard.57.9.545","volume":"57","author":"F Perez-Ruiz","year":"1998","unstructured":"Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, et al. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis. 1998;57(9):545\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2012_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/ard.2008.091462","volume":"68","author":"MK Reinders","year":"2009","unstructured":"Reinders MK, Haagsma C, Jansen TL, et al. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300\u2013600 mg\/day versus benzbromarone 100\u2013200 mg\/day in patients with gout. Ann Rheum Dis. 2009;68(6):892\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2012_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3899\/jrheum.101156","volume":"38","author":"DS Goldfarb","year":"2011","unstructured":"Goldfarb DS, MacDonald PA, Hunt B, et al. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. J Rheumatol. 2011;38(7):1385\u20139.","journal-title":"J Rheumatol"},{"issue":"12","key":"2012_CR11","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.42266","volume":"74","author":"F Yan","year":"2022","unstructured":"Yan F, Xue X, Lu J, et al. Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion. Arthritis Rheumatol. 2022;74(12):2015\u201323.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"2012_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ncprheum0556","volume":"3","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol. 2007;3(8):443\u20139.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"32","key":"2012_CR13","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.2174\/138161205774913273","volume":"11","author":"N Schlesinger","year":"2005","unstructured":"Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des. 2005;11(32):4133\u20138.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"2012_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM199602153340707","volume":"334","author":"BT Emmerson","year":"1996","unstructured":"Emmerson BT. The management of gout. N Engl J Med. 1996;334(7):445\u201351.","journal-title":"N Engl J Med"},{"issue":"7","key":"2012_CR15","first-page":"1350","volume":"29","author":"AG Fam","year":"2002","unstructured":"Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002;29(7):1350\u20135.","journal-title":"J Rheumatol"},{"key":"2012_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752359","volume":"12","author":"PT Georgel","year":"2021","unstructured":"Georgel PT, Georgel P. Where epigenetics meets food intake: their interaction in the development\/severity of gout and therapeutic perspectives. Front Immunol. 2021;12: 752359.","journal-title":"Front Immunol"},{"issue":"2","key":"2012_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088547","volume":"9","author":"TH Chiu","year":"2014","unstructured":"Chiu TH, Huang HY, Chiu YF, et al. Taiwanese vegetarians and omnivores: dietary composition, prevalence of diabetes and IFG. PLoS ONE. 2014;9(2): e88547.","journal-title":"PLoS ONE"},{"issue":"10","key":"2012_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1017\/S000711451400261X","volume":"112","author":"MJ Orlich","year":"2014","unstructured":"Orlich MJ, Jaceldo-Siegl K, Sabate J, et al. Patterns of food consumption among vegetarians and non-vegetarians. Br J Nutr. 2014;112(10):1644\u201353.","journal-title":"Br J Nutr"},{"issue":"3","key":"2012_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.clnu.2019.03.016","volume":"39","author":"THT Chiu","year":"2020","unstructured":"Chiu THT, Liu CH, Chang CC, et al. Vegetarian diet and risk of gout in two separate prospective cohort studies. Clin Nutr. 2020;39(3):837\u201344.","journal-title":"Clin Nutr"},{"issue":"5","key":"2012_CR20","first-page":"773","volume":"32","author":"AG Fam","year":"2005","unstructured":"Fam AG. Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol. 2005;32(5):773\u20137.","journal-title":"J Rheumatol"},{"key":"2012_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.","journal-title":"Nat Commun"},{"issue":"6","key":"2012_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1590\/S0066-782X2001000600004","volume":"76","author":"MR Peixoto","year":"2001","unstructured":"Peixoto MR, Monego ET, Jardim PC, et al. Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol. 2001;76(6):463\u201372.","journal-title":"Arq Bras Cardiol"},{"key":"2012_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3899\/jrheum.140459","volume":"92","author":"JH Moi","year":"2014","unstructured":"Moi JH, Sriranganathan MK, Falzon L, et al. Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviews. J Rheumatol Suppl. 2014;92:26\u201332.","journal-title":"J Rheumatol Suppl"},{"issue":"11","key":"2012_CR24","volume":"11","author":"M Andres","year":"2021","unstructured":"Andres M, Sivera F, Buchbinder R, et al. Dietary supplements for chronic gout. Cochrane Database Syst Rev. 2021;11(11): CD010156.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2012_CR25","first-page":"1859","volume":"35","author":"Z Miao","year":"2008","unstructured":"Miao Z, Li C, Chen Y, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 2008;35(9):1859\u201364.","journal-title":"J Rheumatol"},{"issue":"5","key":"2012_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/0002-9343(74)90634-2","volume":"56","author":"T Yu","year":"1974","unstructured":"Yu T, Yu TF. Milestones in the treatment of gout. Am J Med. 1974;56(5):676\u201385.","journal-title":"Am J Med"},{"key":"2012_CR27","first-page":"34","volume":"19","author":"N Zollner","year":"1973","unstructured":"Zollner N. Influence of various purines on uric acid metabolism. Bibl Nutr Dieta. 1973;19:34\u201343.","journal-title":"Bibl Nutr Dieta"},{"key":"2012_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-4757-1433-3_8","volume":"41","author":"N Zollner","year":"1974","unstructured":"Zollner N, Griebsch A. Diet and gout. Adv Exp Med Biol. 1974;41:435\u201342.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"2012_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0895-4356(90)90095-7","volume":"43","author":"HM Loenen","year":"1990","unstructured":"Loenen HM, Eshuis H, Lowik MR, et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System). J Clin Epidemiol. 1990;43(12):1297\u2013303.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2012_CR30","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2012_CR31","first-page":"903","volume":"32","author":"F Cardona","year":"2005","unstructured":"Cardona F, Tinahones FJ, Collantes E, et al. Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster. J Rheumatol. 2005;32(5):903\u20135.","journal-title":"J Rheumatol"},{"issue":"4","key":"2012_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/acr.24150","volume":"73","author":"Y Gao","year":"2021","unstructured":"Gao Y, Cui LF, Sun YY, et al. Adherence to the dietary approaches to stop hypertension diet and hyperuricemia: a cross-sectional study. Arthritis Care Res (Hoboken). 2021;73(4):603\u201311.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"2012_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/0002-9343(68)90168-X","volume":"45","author":"AR Myers","year":"1968","unstructured":"Myers AR, Epstein FH, Dodge HJ, et al. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med. 1968;45(4):520\u20138.","journal-title":"Am J Med"},{"issue":"21","key":"2012_CR34","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","volume":"266","author":"R Roubenoff","year":"1991","unstructured":"Roubenoff R, Klag MJ, Mead LA, et al. Incidence and risk factors for gout in white men. JAMA. 1991;266(21):3004\u20137.","journal-title":"JAMA"},{"issue":"8","key":"2012_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0895-7061(02)02953-9","volume":"15","author":"S Tsunoda","year":"2002","unstructured":"Tsunoda S, Kamide K, Minami J, et al. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens. 2002;15(8):697\u2013701.","journal-title":"Am J Hypertens"},{"issue":"10","key":"2012_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/acr.23515","volume":"70","author":"SP Juraschek","year":"2018","unstructured":"Juraschek SP, White K, Tang O, et al. Effects of a dietary approach to stop hypertension (dash) diet intervention on serum uric acid in African Americans with hypertension. Arthritis Care Res (Hoboken). 2018;70(10):1509\u201316.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"2012_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2337\/dc07-1463","volume":"31","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care. 2008;31(1):165\u20139.","journal-title":"Diabetes Care"},{"issue":"9","key":"2012_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/medicina55090600","volume":"55","author":"A Oral","year":"2019","unstructured":"Oral A, Sahin T, Turker F, et al. Relationship between serum uric acid levels and nonalcoholic fatty liver disease in non-obese patients. Medicina (Kaunas). 2019;55(9):600.","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"2012_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Kaze AD, McMullan CJ, et al. Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis. 2018;71(3):362\u201370.","journal-title":"Am J Kidney Dis"},{"issue":"7789","key":"2012_CR40","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(72)92271-4","volume":"2","author":"A Nicholls","year":"1972","unstructured":"Nicholls A, Scott JT. Effect of weight-loss on plasma and urinary levels of uric acid. Lancet. 1972;2(7789):1223\u20134.","journal-title":"Lancet"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02012-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T18:03:37Z","timestamp":1725300217000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02012-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02012-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with Declaration of Helsinki. The study was approved by the ethics committee of the Affiliated Hospital of Qingdao University. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}